TH96108A - Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4- illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (monoate Thanolamine) - Google Patents
Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4- illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (monoate Thanolamine)Info
- Publication number
- TH96108A TH96108A TH701003817A TH0701003817A TH96108A TH 96108 A TH96108 A TH 96108A TH 701003817 A TH701003817 A TH 701003817A TH 0701003817 A TH0701003817 A TH 0701003817A TH 96108 A TH96108 A TH 96108A
- Authority
- TH
- Thailand
- Prior art keywords
- pyrazol
- biphenyl
- dihydro
- oxo
- methyl
- Prior art date
Links
- 239000005426 pharmaceutical component Substances 0.000 title claims abstract 5
- -1 3,4-dimethylphenyl Chemical group 0.000 title 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 235000010290 biphenyl Nutrition 0.000 claims 2
- 239000004305 biphenyl Substances 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 2
- TYYXAUPVEKKAFG-HTQZHWFGSA-N 2-aminoethanol;3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazinylidene]-6-oxocyclohexa-1,3-dien-1-yl]benzoic acid Chemical compound NCCO.NCCO.O=C1C(N\N=C/2C(C(=CC=C\2)C=2C=C(C=CC=2)C(O)=O)=O)=C(C)NN1C1=CC=C(C)C(C)=C1 TYYXAUPVEKKAFG-HTQZHWFGSA-N 0.000 abstract 2
- 229960001827 Eltrombopag olamine Drugs 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
Abstract
DC60 (12/12/51) ที่เปิดเผยเป็นองค์ประกอบทางเภสัชกรรมรูปแบบใหม่ที่มี 3'-[(2Z)-[1-(3,4-ไดเม ทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H-ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี- [1,1'ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโนเอทธาโนลามีน) (เอลตรอมโบแพกโอลามีน) และ กระบวนการสำหรับการเตรียมสารดังกล่าว ที่เปิดเผยเป็นองค์ประกอบทางเภสัชกรรมรูปแบบใหม่ที่มี 3'-[(2Z)-[1-(3,4-ไดเม ทธิลฟีนิล)-1,5-ไดไฮโดร-3-เมทธิล-5-ออกโซ-4H-ไพราซอล-4-อิลลีดีน]ไฮดราซิโน]-2'-ไฮดรอกซี- [1,1'ไบฟีนิล]-3-คาร์บอกซิลิกแอซิดบิส-(โมโนเอทธาโนลามีน) (เอลตรอมโบแพกโอลามีน) และ กระบวนการสำหรับการเตรียมสารดังกล่าว สิทธิบัตรยา DC60 (12/12/51) disclosed is a new form of pharmaceutical component with 3 '- ((2Z) - (1- (3,4-Dimé Tthylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxyl Oxy- [1,1 'biphenyl] -3-carboxylic acid bis- (monoethanolamine) (eltrombopagolamine) and Process for the preparation of such substances Disclosed is a new form of pharmaceutical component that has 3 '- ((2Z) - (1- (3,4-Dimé Tthylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-illedene] hydracino] -2'-hydroxyl Oxy- [1,1 'biphenyl] -3-carboxylic acid bis- (monoethanolamine) (eltrombopagolamine) and Process for the preparation of such substances; drug patents
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH96108B TH96108B (en) | 2009-06-18 |
TH96108A true TH96108A (en) | 2009-06-18 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1117284T1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
BRPI0310094B8 (en) | 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene] acid bis(monoethanolamine) compound hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid, pharmaceutical composition and processes for preparing said compound and pharmaceutical composition | |
AR058433A1 (en) | DERIVATIVE OF 1,1-DIOXIDE OF 1,4-BENZOTIAZEPIN, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THIS COMPOSITE AND ITS USE | |
GT200600258A (en) | DERIVATIVES OF N- (PIRIDIN-2-IL) -SULFONAMIDE | |
BRPI0814593A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
BRPI0620229A8 (en) | formulation | |
AR052270A1 (en) | PROCEDURE TO COMBAT FUNGICAL DISEASES IN LEGUMINOUS | |
BRPI0809667A2 (en) | COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND | |
CL2007001325A1 (en) | COMPOUNDS DERIVED FROM BICYCLES, CEPT INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, AMONG OTHER ILLNESSES. | |
BRPI0717369A2 (en) | COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
AR057885A1 (en) | ACID 1- (1- (2- ETOXIETIL) - 1- ETIL-7- (4- METHYLPIRIDIN -2- ILAMINO) - 1H PIRAZOLO (4,3-D) PIRIMIDIN -5- IL) PIPERIDINE -4- CARBOXYL AND SALTS OF THE SAME. PHARMACEUTICAL COMPOSITIONS. | |
TH96108A (en) | Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydro-3-methyl-5-oxo-4H-pyrazol- 4- illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (monoate Thanolamine) | |
TH96108B (en) | Pharmaceutical components that contain 3 '- ((2Z) - (1- (3,4-dimethylphenyl) -1,5-dihydrochro-3-methyl-5-oxho-4H-pyrazol -4-illydine] hydrazino] -2'-hydroxy- [1,1'-biphenyl] -3-carboxylic acidbis- (mono A Tthanolamine) | |
TH89968A (en) | The immidazole compound was replaced as a KSP inhibitor. | |
TH84733A (en) | New compound | |
TH75686A (en) | New compound | |
TH85281A (en) | Taigecyclin and methods of its preparation | |
TH157551A (en) | Heterocyclic inhibitors Aspartil Protease | |
RU2005132798A (en) | PROTECTIVE ENVIRONMENT FOR THE PRODUCTION OF VIRUSVACCINES IN POULTRY | |
TH73069A (en) | Indolisine derivatives replaced with new 1,2,3,6,7,8, which are inhibitors of FGFs, a method for preparing them, and a pharmaceutical mixtures that contain them. | |
UA96261C2 (en) | Pharmaceutical compositions containing eltrombopag olamine and processes for the preparation thereof | |
TH98869A (en) | Combined Drug Therapy with 5-HTP | |
TH92800A (en) | New compound | |
TH146881A (en) | Salt of N- (6- (cis-2,6-dimethyl morpholin-4-il) pyridine-3-il) -2-methyl-4'- (Trifluoromethoxy) [1,1'-biphenyl] -3-carboxamide | |
TH107322A (en) |